macromastia

Gestational macromastia has been treated with drugs alone without surgery.

In the majority of cases of macromastia, surgery is medically unnecessary, depending on body height.

Bromocriptine has completely treated gestational macromastia eliminating the need for reduction surgery, in a recent case.

One of the most severe cases of macromastia reported in the world medical literature was from Ilorin in Nigeria.

Hypertrophy of the breast (gigantomastia and macromastia)

Whereas macromastia usually develops in consequence to the hypertrophy (overdevelopment) of adipose fat, rather than to milk-gland hypertrophy.

When gigantomastia occurs in young women during puberty, the medical condition is known as juvenile macromastia or juvenile gigantomastia and sometimes as Virginal breast hypertrophy.

Some resources distinguish between macromastia, where excessive tissue is less than 2.5 kg, and gigantomastia, where excessive tissue is more than 2.5 kg.

The treatment of macromastia and gigantomastia with the Lejour technique applies a vertical-incision, a superior pedicle, breast liposuction, and wide undermining of the skin of the lower portion of the breast.

Breast hypertrophy is classified in one of five ways: as either pubertal (virginal hypertrophy), gestational (gravid macromastia), in adult women without any obvious cause, associated with penicillamine therapy, and associated with extreme obesity.

Many definitions of macromastia and gigantomastia are based on the term of "excessive breast tissue", and are therefore somewhat arbitrary, as excessive tissue can often be regarded only from an aesthetic viewpoint and not from a medical one.

Macromastia can be manifested either as a unilateral condition or as a bilateral condition (single-breasted enlargement or double-breasted enlargement) that can occur in combination with sagging, breast ptosis that is determined by the degree to which the nipple has descended below the inframammary fold (IMF).